#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1266	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1284	52.9	0	.	p	.	0	K29T	NONSYN	85	87	AAG	370	372	ACG	68;70;69	A;C;G	68;70;68	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	4478	Escherichia_coli_EF_Tu	1185	1177	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1177	175.5	0	HET	.	.	.	T135C	.	135	135	T	134	134	T	135	T,C	90,40	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	4478	Escherichia_coli_EF_Tu	1185	1177	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1177	175.5	0	HET	.	.	.	C216T	.	216	216	C	215	215	C	168	C,T	91,76	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	4478	Escherichia_coli_EF_Tu	1185	1177	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1177	175.5	0	HET	.	.	.	C954T	.	954	954	C	953	953	C	166	C,T	96,70	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1734	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1894	49.0	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1605	1607	AAA	30;30;29	A;A;A	29;30;28	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	2368	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1855	68.2	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1288	1290	GAA	89;92;91	G;A;A	89;92;91	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	539	502	H_NS	414	414	98.79	H_NS.l15.c4.ctg.1	1010	26.6	0	.	p	.	0	M123I	NONSYN	367	369	ATG	660	662	ATA	23;25;25	A;T;A	23;25;25	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	296	G	294	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	268	C	268	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	246	C,T	243,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	273	T	271	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	305	C	305	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	200	C,T	199,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	199	A	199	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	202	A	202	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	214	A	212	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	205	T	205	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	205	C	205	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	205	C	204	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	204	A	204	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	199	G	197	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	203	C	203	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	221	T	220	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	287	G	287	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	316	G	315	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	326	T	326	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	294	TGG,TG	270,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	273	G	270	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	211	C	210	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	197	A	196	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	195	C	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	193	C	193	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	94	A	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	94	A	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	92	G	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	81	C	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	161	T	160	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	180	G	180	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	144	T	144	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	349	C	347	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	6738	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	763	205.9	0	HET	.	.	.	C1139A	.	1139	1139	C	99	99	C	258	C,A	224,34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1754	PmrB_1	1092	1092	99.27	PmrB_1.l15.c30.ctg.1	1685	55.7	0	.	p	.	0	H2R	NONSYN	4	6	CAT	313	315	CGT	56;57;56	C;G;T	55;57;56	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1754	PmrB_1	1092	1092	99.27	PmrB_1.l15.c30.ctg.1	1685	55.7	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1156	1158	GGC	56;55;59	G;G;C	56;55;59	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2426	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2241	58.1	0	.	p	.	0	R8S	NONSYN	22	24	AGA	371	373	AGC	43;43;44	A;G;C	43;43;43	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2426	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2241	58.1	0	.	p	.	0	I142L	NONSYN	424	426	ATA	773	775	CTA	62;62;62	C;T;A	61;62;62	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2426	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2241	58.1	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1292	1294	CAA	77;82;82	C;A;A	76;81;81	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2426	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2241	58.1	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1391	1393	GGT	61;61;63	G;G;T	60;61;63	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2426	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2241	58.1	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1961	1963	GTT	61;60;59	G;T;T	61;60;59	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1038	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1730	32.1	0	.	p	.	0	A125E	NONSYN	373	375	GCA	680	682	GAA	39;39;38	G;A;A	39;38;38	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1038	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1730	32.1	0	.	p	.	0	M185T	NONSYN	553	555	ATG	860	862	ACC	17;17;18	A;C;C	17;17;18	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1038	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1730	32.1	0	.	p	.	0	S225T	NONSYN	673	675	TCC	980	982	ACT	29;29;29	A;C;T	29;29;29	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1038	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1730	32.1	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1370	1372	ATC	28;29;31	A;T;C	28;29;31	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1474	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1570	50.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_1.3000873.AL513383.161910_162771.1951	TEM_1.3000873.AL513383.161910_162771.1951	1	0	27	6968	TEM_1+	861	861	99.88	TEM_1+.l6.c30.ctg.1	1416	261.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-1;TEM-1 is a broad-spectrum beta-lactamase found in many Gram-negative bacteria.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	4248	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3576	63.8	0	.	p	.	0	T85I	NONSYN	253	255	ACC	505	507	ATC	75;73;73	A;T;C	75;73;72	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	4248	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3576	63.8	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2218	2220	AAG	54;53;52	A;A;G	54;53;52	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1712	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1668	55.0	0	.	p	.	0	A22V	NONSYN	64	66	GCC	336	338	GTC	41;43;45	G;T;C	41;43;44	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1712	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1668	55.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1077	1079	TGC	73;71;73	T;G;C	73;71;72	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	4680	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3730	67.0	0	.	p	.	0	S46trunc	TRUNC	136	136	T	495	495	T	52	T	52	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	4680	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3730	67.0	0	.	p	.	0	G148D	NONSYN	442	444	GGC	801	803	GAC	66;67;63	G;A;C	66;67;63	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	4680	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3730	67.0	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1077	1079	TTA	48;49;47	T;T;A	46;49;47	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	4680	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3730	67.0	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2154	2156	AAT	78;79;80	A;A;T	78;78;78	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	4680	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3730	67.0	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2268	2270	AGT	57;57;57	A;G;T	56;57;56	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	4680	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3730	67.0	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2667	2669	GTG	76;75;77	G;T;G	76;74;77	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	4680	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3730	67.0	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3222	3224	AAG	57;57;57	A,G;A;G	55,1;57;57	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	1038	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1324	42.1	1	SNP	p	R45C	0	.	.	133	135	CGC	492	494	CGC	52;51;51	C;G;C	52;51;51	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	998	acrS	663	663	98.79	acrS.l15.c30.ctg.1	1199	44.5	0	.	p	.	0	L34F	NONSYN	100	102	CTC	357	359	TTC	36;36;37	T;T,C;C	36;35,1;37	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	998	acrS	663	663	98.79	acrS.l15.c30.ctg.1	1199	44.5	0	.	p	.	0	E122G	NONSYN	364	366	GAG	621	623	GGG	70;69;68	G;G;G	70;69;68	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1224	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1281	51.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	683	685	CTT	72;70;70	C;T;T	72;70;70	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3938	alaS	2631	2631	98.82	alaS.l15.c30.ctg.1	3281	64.5	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2182	2184	GCA	91;90;91	G;C;A	91;90;90	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3938	alaS	2631	2631	98.82	alaS.l15.c30.ctg.1	3281	64.5	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2443	2445	ACC	65;65;67	A;C;C	61;64;67	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3938	alaS	2631	2631	98.82	alaS.l15.c30.ctg.1	3281	64.5	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2752	2754	GCC	59;61;60	G,C;C;C	58,1;59;60	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2206	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.2	2392	48.0	0	.	p	.	0	G37A	NONSYN	109	111	GGT	455	457	GCT	18;18;18	G;C;T	18;18;18	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2206	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.2	2392	48.0	0	.	p	.	0	D77E	NONSYN	229	231	GAT	575	577	GAG	17;16;17	G;A;G	17;15;17	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2206	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.2	2392	48.0	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	611	613	TGC	19;19;20	T;G;C	19;19;20	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2206	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.2	2392	48.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	794	796	GTT	44;46;46	G;T;T	44;45;45	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2206	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.2	2392	48.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	944	946	CAC	57;56;56	C;A;C	57;56;56	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2206	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.2	2392	48.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1229	1231	ATG	77;77;77	A;T;G	75;77;77	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2206	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.2	2392	48.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2225	2227	CGC	46;43;43	C;G;C	46;43;43	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1076	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1330	43.0	0	.	p	.	0	S221T	NONSYN	661	663	AGC	887	889	ACC	38;38;37	A;C;C	38;38;37	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1076	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1330	43.0	0	.	p	.	0	P225S	NONSYN	673	675	CCG	899	901	TCG	30;33;34	T;C;G	30;32;34	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	824	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1277	34.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1510	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2048	39.6	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1405	1407	AAA	22;23;23	A;A;A	20;23;23	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1510	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2048	39.6	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1417	1419	GAG	21;21;22	G;A;G	21;21;22	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1510	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2048	39.6	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1423	1425	CAC	28;29;29	C;A;C	28;29;28	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1510	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2048	39.6	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1477	1479	GAG	43;43;43	G;A;G	43;42;43	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	2260	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1801	66.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1406	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1468	51.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	1182	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1419	44.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA14.3002859.EU780012.2162_2645.206	dfrA14.3002859.EU780012.2162_2645.206	1	0	27	2524	dfrA14	483	483	100.0	dfrA14.l15.c30.ctg.1	1145	118.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA14 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA14
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1584	emrA	1173	1173	98.38	emrA.l15.c30.ctg.1	1753	48.6	0	.	p	.	0	I219V	NONSYN	655	657	ATC	974	976	GTC	66;66;65	G;T;C	65;66;65	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	2342	emrB	1539	1539	99.81	emrB.l15.c30.ctg.1	2172	57.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1742	emrD	1191	1191	98.49	emrD.l15.c30.ctg.1	1849	50.4	0	.	p	.	0	A53S	NONSYN	157	159	GCT	547	549	TCT	52;50;47	T,G;C;T	50,1;50;46	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1742	emrD	1191	1191	98.49	emrD.l15.c30.ctg.1	1849	50.4	0	.	p	.	0	G209S	NONSYN	625	627	GGC	1015	1017	AGC	74;73;73	A;G;C	74;73;73	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	68	emrE_1	333	224	91.07	emrE_1.l15.c30.ctg.1	259	4.4	0	.	p	.	0	I100V	NONSYN	298	300	ATT	189	191	GTC	3;3;3	G;T;C	3;3;3	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	68	emrE_1	333	224	91.07	emrE_1.l15.c30.ctg.1	259	4.4	0	.	p	.	0	T108A	NONSYN	322	324	ACA	213	215	GCA	5;5;5	G;C;A	5;5;5	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1206	emrK	1056	1056	98.11	emrK.l15.c30.ctg.1	1683	38.4	0	.	p	.	0	S22F	NONSYN	64	66	TCT	399	401	TTT	27;26;25	T;T;T	27;26;25	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1206	emrK	1056	1056	98.11	emrK.l15.c30.ctg.1	1683	38.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	861	863	AGG	33;32;32	A;G;G	33;32;31	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1206	emrK	1056	1056	98.11	emrK.l15.c30.ctg.1	1683	38.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1251	1253	GAC	41;45;45	G;A;C	41;45;45	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	998	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1300	41.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	2028	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2165	50.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	920	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1194	41.0	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	463	465	CTG	43;44;47	C;T;G	43;44;47	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	398	400	ATA	19;19;20	A;T;A	19;18;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	410	412	GTA	32;34;34	G;T;A	32;34;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	563	565	ACG	31;33;36	A;C;G	31;33;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	626	628	GAA	35;35;36	G;A;A	35;35;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	665	667	GCT	42;42;42	G;C;T	42;42;42	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	683	685	GAT	44;46;46	G;A;T	44;46;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	770	772	TCA	38;38;33	T;C;A	38;38;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	899	901	CAG	30;28;27	C;A;G	30;28;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1037	1039	GTT	36;36;33	G;T;T	36;36;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1193	1195	GAT	23;24;26	G;A;T	23;24;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1361	1363	AAT	25;25;26	A;A;T	25;25;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1382	1384	TTA	19;19;18	T;T;A	19;19;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1583	1585	AAA	42;42;42	A;A;A	42;42;42	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2318	2320	CAT	41;40;41	C;A;T	41;40;40	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2372	2374	CAT	44;44;42	C;A;T	44;44;42	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2390	2392	AGA	40;37;37	A;G;A	40;37;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2405	2407	AAT	36;37;37	A;A;T	35;37;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2552	2554	TCC	34;30;28	T;C;C	34;30;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2717	2719	ATT	50;49;47	A;T;T	49;48;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2738	2740	GAT	53;53;53	G;A,G;T	53;52,1;53	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2852	2854	GTT	62;61;59	G;T;T	61;61;59	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3950	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4105	51.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3137	3139	CAC	64;63;61	C;A;C	64;62;61	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1286	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1393	49.5	1	SNP	p	P64R	0	.	.	190	192	CCA	474	476	CCA	75;73;73	C;C;A	74;72;66	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1286	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1393	49.5	1	SNP	p	P64L	0	.	.	190	192	CCA	474	476	CCA	75;73;73	C;C;A	74;72;66	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1286	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1393	49.5	1	SNP	p	P64S	0	.	.	190	192	CCA	474	476	CCA	75;73;73	C;C;A	74;72;66	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1286	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1393	49.5	1	SNP	p	P64H	0	.	.	190	192	CCA	474	476	CCA	75;73;73	C;C;A	74;72;66	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1286	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1393	49.5	1	SNP	p	P64A	0	.	.	190	192	CCA	474	476	CCA	75;73;73	C;C;A	74;72;66	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	934	gadE	528	528	100.0	gadE.l6.c30.ctg.1	1189	42.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	Q21H	NONSYN	61	63	CAA	10	12	CAT	1;1;1	C;A;T	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	L31V	NONSYN	91	93	CTG	40	42	GTG	5;5;5	G;T;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	D34E	NONSYN	100	102	GAT	49	51	GAG	5;5;5	G;A;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	L46P	NONSYN	136	138	CTG	85	87	CCG	3;4;4	C;C;G	3;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	E54D	NONSYN	160	162	GAA	109	111	GAT	12;13;13	G;A;T	11;13;12	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	I88M	NONSYN	262	264	ATA	211	213	ATG	7;7;6	A;T;G	7;7;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	214	216	CCG	6;6;7	C;C;G	6;6;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	D100E	NONSYN	298	300	GAC	247	249	GAA	9;9;9	G;A;A	9;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	P101S	NONSYN	301	303	CCC	250	252	TCC	9;9;9	T;C;C	9;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	R102G	NONSYN	304	306	CGG	253	255	GGG	10;10;10	G;G;G	10;10;10	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	K110N	NONSYN	328	330	AAA	277	279	AAT	8;9;8	A;A;T	8;9;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	266	gadW	729	678	94.25	gadW.l15.c30.ctg.1	832	16.7	0	.	p	.	0	S234A	NONSYN	700	702	TCG	649	651	GCG	17;17;17	G;C;G	17;17;17	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	958	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1402	36.8	0	.	p	.	0	F53L	NONSYN	157	159	TTC	450	452	TTA	43;42;39	T;T;A	43;42;39	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	958	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1402	36.8	0	.	p	.	0	V79I	NONSYN	235	237	GTT	528	530	ATT	50;49;48	A;T;T	50;49;48	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	958	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1402	36.8	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1029	1031	GGA	37;37;36	G;G;A	37;37;36	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	958	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1402	36.8	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1035	1037	CCG	32;32;32	C;C;G	32;31;32	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3584	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3182	60.5	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2301	2303	GAA	47;47;49	G;A;A	46;47;47	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3584	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3182	60.5	1	SNP	p	S83W	0	.	.	247	249	TCG	516	518	TCG	82;81;84	T;C;G	82;78;84	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3584	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3182	60.5	1	SNP	p	S83L	0	.	.	247	249	TCG	516	518	TCG	82;81;84	T;C;G	82;78;84	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3584	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3182	60.5	1	SNP	p	S83I	0	.	.	247	249	TCG	516	518	TCG	82;81;84	T;C;G	82;78;84	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3584	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3182	60.5	1	SNP	p	D87H	0	.	.	259	261	GAC	528	530	GAC	79;79;79	G;A;C	76;75;79	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3584	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3182	60.5	1	SNP	p	D87V	0	.	.	259	261	GAC	528	530	GAC	79;79;79	G;A;C	76;75;79	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3584	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3182	60.5	1	SNP	p	D87Y	0	.	.	259	261	GAC	528	530	GAC	79;79;79	G;A;C	76;75;79	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3584	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3182	60.5	1	SNP	p	D87N	0	.	.	259	261	GAC	528	530	GAC	79;79;79	G;A;C	76;75;79	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3584	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3182	60.5	1	SNP	p	D87G	0	.	.	259	261	GAC	528	530	GAC	79;79;79	G;A;C	76;75;79	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3962	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2846	74.3	1	SNP	p	R136L	0	.	.	406	408	CGC	626	628	CGC	83;84;86	C;G;C	83;83;85	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3962	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2846	74.3	1	SNP	p	R136G	0	.	.	406	408	CGC	626	628	CGC	83;84;86	C;G;C	83;83;85	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3962	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2846	74.3	1	SNP	p	R136I	0	.	.	406	408	CGC	626	628	CGC	83;84;86	C;G;C	83;83;85	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3962	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2846	74.3	1	SNP	p	R136H	0	.	.	406	408	CGC	626	628	CGC	83;84;86	C;G;C	83;83;85	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3962	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2846	74.3	1	SNP	p	R136E	0	.	.	406	408	CGC	626	628	CGC	83;84;86	C;G;C	83;83;85	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3962	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2846	74.3	1	SNP	p	R136C	0	.	.	406	408	CGC	626	628	CGC	83;84;86	C;G;C	83;83;85	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3962	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2846	74.3	1	SNP	p	R136S	0	.	.	406	408	CGC	626	628	CGC	83;84;86	C;G;C	83;83;85	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	812	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1272	34.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	603	605	CCG	41;41;42	C;C;G	40;40;42	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	812	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1272	34.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	756	758	GCC	39;38;38	G;C;C	39;38;38	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	531	1538	leuO	945	945	99.15	leuO.l15.c30.ctg.1	1524	54.2	0	.	p	.	0	P9S	NONSYN	25	27	CCA	314	316	TCA	32;32;34	T;C;A	31;32;34	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	531	1538	leuO	945	945	99.15	leuO.l15.c30.ctg.1	1524	54.2	0	.	p	.	0	Q156trunc	TRUNC	466	466	C	755	755	T	89	T,C,G	87,1,1	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	478	marA	384	384	99.74	marA.l15.c4.ctg.1	974	26.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	738	740	AGC	15;15;15	A;G;C	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	840	842	CAT	6;5;5	C;A;T	6;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	V45E	0	.	.	133	135	GTG	564	566	GTG	52;52;52	G;T;G	52;51;51	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	I49S	0	.	.	145	147	ATC	576	578	ATC	51;50;49	A;T;C	50;50;49	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	A70T	0	.	.	208	210	GCA	639	641	GCA	33;33;34	G;C;A,G	33;33;32,1	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	R73S	0	.	.	217	219	CGT	648	650	CGT	34;34;34	C;G;T	34;34;34	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	R73C	0	.	.	217	219	CGT	648	650	CGT	34;34;34	C;G;T	34;34;34	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	R77C	0	.	.	229	231	CGC	660	662	CGC	34;35;35	C;G;C	34;35;34	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	R77L	0	.	.	229	231	CGC	660	662	CGC	34;35;35	C;G;C	34;35;34	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	L78M	0	.	.	232	234	CTG	663	665	CTG	36;36;34	C;T;G	36;36;34	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	R94S	0	.	.	280	282	CGC	711	713	CGC	18;18;17	C;G;C	18;18;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	R94H	0	.	.	280	282	CGC	711	713	CGC	18;18;17	C;G;C	18;18;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	310	marR	435	435	97.7	marR.l6.c4.ctg.1	1060	15.8	1	SNP	p	V96E	0	.	.	286	288	GTA	717	719	GTA	15;15;15	G;T;A	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	S7F	NONSYN	19	21	TCC	191	193	TTC	13;12;12	T;T;C	13;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	278	280	ATC	26;25;23	A;T;C	26;25;23	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	296	298	GCC	10;11;11	G;C;C	10;11;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	299	301	GTG	12;12;12	G;T;G	12;11;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	326	328	GAT	16;15;16	G;A;T	16;15;16	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	347	349	ACC	23;23;23	A;C;C	22;23;23	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	374	376	TTA	22;21;21	T;T;A	22;21;21	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	515	517	CAG	63;62;61	C;A;G	62;62;61	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	554	556	GCC	49;50;51	G;C;C	49;50;51	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	659	661	GCG	47;48;48	G;C;G	47;47;48	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	863	865	GTT	30;32;32	G;T;T	25;28;31	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1134	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1691	35.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1025	1025	C	46	C	46	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1156	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1746	35.6	0	.	p	.	0	V12trunc	TRUNC	34	34	G	288	288	G	46	G	46	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1156	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1746	35.6	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	345	347	CAG	20;21;21	C;A;G	20;21;21	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1156	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1746	35.6	0	.	p	.	0	T83I	NONSYN	247	249	ACC	495	497	ATC	30;28;27	A;T;C	30;28;27	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1156	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1746	35.6	0	.	p	.	0	I99M	NONSYN	295	297	ATA	543	545	ATG	29;31;32	A;T;G	29;31;32	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1156	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1746	35.6	0	.	p	.	0	A130T	NONSYN	388	390	GCC	636	638	ACC	32;31;31	A;C;C	32;31;31	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1156	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1746	35.6	0	.	p	.	0	T157N	NONSYN	469	471	ACC	717	719	AAC	29;30;30	A;A;C	28;30;30	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3538	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3697	51.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2064	2066	ACC	51;48;47	A;C;C	51;48;47	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3538	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3697	51.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2457	2459	CAA	53;52;54	C;A;A	51;52;52	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3538	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3697	51.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2625	2627	ATT	34;34;34	A;T;T	33;33;33	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3538	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3697	51.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2709	2711	GTT	41;40;40	G;T;T	41;40;40	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3538	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3697	51.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2817	2819	GAG	38;38;39	G;A;G	38;38;39	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3538	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3697	51.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3045	3047	ATG	31;32;33	A;T;G	31;31;33	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3538	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3697	51.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3180	3182	GAT	46;47;49	G;A;T	46;47;49	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3220	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3564	48.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	352	354	ATG	35;36;35	A;T;G	34;34;35	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3220	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3564	48.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	838	840	ATC	52;51;50	A;T;C	51;50;47	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3220	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3564	48.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3154	3156	CAC	15;15;15	C;A;C	15;15;15	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1600	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2070	41.5	0	.	p	.	0	D3E	NONSYN	7	9	GAT	319	321	GAA	26;26;26	G;A;A	26;26;26	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1600	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2070	41.5	0	.	p	.	0	T226A	NONSYN	676	678	ACG	988	990	GCG	40;40;42	G;C;G	39;40;41	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1600	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2070	41.5	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1330	1332	ATC	56;54;52	A;T;C	55;53;51	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1600	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2070	41.5	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1633	1635	TTT	53;51;51	T;T;T	53;51;51	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	2224	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1786	66.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4814	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3719	69.5	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1209	1211	ACC	54;53;52	A;C,A;C	54;48,1;50	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4814	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3719	69.5	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2451	2453	GAC	68;68;68	G;A;C	68;67;68	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1680	mdtG	1227	1047	99.43	mdtG.l6.c30.ctg.1	1725	43.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	745	747	ATC	49;47;46	A;T;C	49;46;46	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1680	mdtG	1227	182	99.45	mdtG.l6.c30.ctg.2	655	22.8	0	.	p	.	0	E5G	NONSYN	13	15	GAA	224	226	GGA	18;23;22	G;G;A	18;23;22	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1234	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1784	37.2	0	.	p	.	0	G134C	NONSYN	400	402	GGT	695	697	TGT	49;49;50	T;G;T	49;49;50	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1234	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1784	37.2	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1265	1267	TTG	52;52;48	T;T;G	52;52;48	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1234	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1784	37.2	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1370	1372	CAG	31;32;32	C;A;G	29;31;32	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1234	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1784	37.2	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1475	1477	ACG	18;20;20	A;C;G	18;20;20	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1830	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1821	53.9	0	.	p	.	0	A185S	NONSYN	553	555	GCC	862	864	TCC	65;65;66	T;C;C	62;64;65	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1296	mdtN	1032	1032	98.16	mdtN.l15.c30.ctg.1	1751	39.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	724	726	ATT	35;36;40	A;T;T	35;35;40	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	356	358	ATG	29;31;32	A;T;G	29;31;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	422	424	ATC	35;35;38	A;T;C	35;35;38	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	671	673	CGC	55;52;51	C;G;C	55;52;51	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	1037	1039	AGC	48;47;48	A;G;C	47;46;48	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1238	1240	GTG	55;55;55	G;T;G	55;53;55	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1301	1303	AAC	44;44;47	A;A;C	42;41;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1346	1348	GTC	53;56;54	G;T;C	53;55;54	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1376	1378	ATA	64;64;64	A;T;A	64;64;63	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1484	1486	TCT	53;57;60	T;C,T;T	53;56,1;60	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1871	1873	GCG	55;54;54	G;C;G	55;53;53	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2610	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2766	50.6	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2084	2086	ATC	61;61;60	A;T;C	61;59;59	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1646	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1943	45.4	0	.	p	.	0	S129A	NONSYN	385	387	TCA	632	634	GCG	50;47;48	G;C;G	50;47;47	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1646	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1943	45.4	0	.	p	.	0	A187T	NONSYN	559	561	GCC	806	808	ACC	57;58;56	A;C;C	57;57;56	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1646	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1943	45.4	0	.	p	.	0	H211R	NONSYN	631	633	CAC	878	880	CGC	66;68;68	C;G;C	66;68;67	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1646	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1943	45.4	0	.	p	.	0	V250A	NONSYN	748	750	GTT	995	997	GCT	53;53;54	G;C;T	52;53;54	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1646	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1943	45.4	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1079	1081	AAA	41;40;39	A;A;A	39;39;38	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1646	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1943	45.4	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1097	1099	CGA	47;50;52	C;G;A	47;50;51	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1646	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1943	45.4	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1262	1264	GCC	38;38;39	G;C;C	38;37;38	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1646	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1943	45.4	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1274	1276	GAT	44;44;46	G;A;T	43;43;45	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1646	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1943	45.4	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1691	1693	GCT	24;22;22	G;C;T	23;22;22	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	4128	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	4186	53.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1685	1687	AAG	30;30;31	A;A;G	30;30;31	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	4128	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	4186	53.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2762	2764	CTG	68;68;65	C;T;G	67;67;65	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	264	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	839	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2348	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2277	55.3	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1073	1075	AAC	57;57;58	A;A;C	57;55;58	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2348	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2277	55.3	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1619	1621	ATA	60;62;64	A;T;A	60;61;63	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	2010	murA_12	1260	1260	98.41	murA_12.l6.c30.ctg.1	1930	55.9	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1402	1404	GTG	57;58;59	G;T;G	57;58;59	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	2010	murA_12	1260	1260	98.41	murA_12.l6.c30.ctg.1	1930	55.9	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1480	1482	GAT	85;82;82	G;A,G;T	85;81,1;82	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	2010	murA_12	1260	1260	98.41	murA_12.l6.c30.ctg.1	1930	55.9	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1483	1485	CTG	79;80;79	C;T;G	78;80;79	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	555	942	nfsA	723	723	98.95	nfsA.l15.c30.ctg.1	1191	37.1	0	.	p	.	0	R27C	NONSYN	79	81	CGT	270	272	TGT	37;38;37	T;G;T	37;38;37	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	555	942	nfsA	723	723	98.95	nfsA.l15.c30.ctg.1	1191	37.1	0	.	p	.	0	I117T	NONSYN	349	351	ATC	540	542	ACC	55;56;56	A;C;C	54;55;56	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	555	942	nfsA	723	723	98.95	nfsA.l15.c30.ctg.1	1191	37.1	0	.	p	.	0	G187D	NONSYN	559	561	GGC	750	752	GAC	54;54;53	G;A;C	54;53;53	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	555	942	nfsA	723	723	98.95	nfsA.l15.c30.ctg.1	1191	37.1	1	SNP	p	S33R	0	.	.	97	99	AGC	288	290	AGC	46;45;45	A;G;C	46;45;45	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	555	942	nfsA	723	723	98.95	nfsA.l15.c30.ctg.1	1191	37.1	1	SNP	p	G131D	0	.	.	391	393	GGC	582	584	GGC	51;52;52	G;G;C	51;52;50	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	555	942	nfsA	723	723	98.95	nfsA.l15.c30.ctg.1	1191	37.1	1	SNP	p	R203L	0	.	.	607	609	CGT	798	800	CGT	61;59;58	C;G;T	61;59;58	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	555	942	nfsA	723	723	98.95	nfsA.l15.c30.ctg.1	1191	37.1	1	SNP	p	R203C	0	.	.	607	609	CGT	798	800	CGT	61;59;58	C;G;T	61;59;58	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	555	942	nfsA	723	70	100.0	nfsA.l15.c30.ctg.2	279	15.4	1	SNP	p	R15C	0	.	.	43	45	CGC	250	252	CGC	55;52;49	C;G;C	55;52;49	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1812	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1675	57.9	1	SNP	p	G141E	0	.	.	421	423	GGT	694	696	GGT	83;85;85	G;G;T	82;85;84	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1812	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1675	57.9	1	SNP	p	G141D	0	.	.	421	423	GGT	694	696	GGT	83;85;85	G;G;T	82;85;84	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1812	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1675	57.9	1	SNP	p	R154D	0	.	.	460	462	CGT	733	735	CGT	78;79;78	C;G;T	78;79;78	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1812	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1675	57.9	1	SNP	p	R154A	0	.	.	460	462	CGT	733	735	CGT	78;79;78	C;G;T	78;79;78	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3608	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2788	69.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1899	1901	TCG	85;86;83	T,A;C;G	83,1;85;82	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3608	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2788	69.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2514	2516	AAC	47;47;46	A;A;C	47;46;46	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3608	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2788	69.6	1	SNP	p	A85T	0	.	.	253	255	GCG	528	530	GCG	100;99;99	G;C;G	99;98;98	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3608	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2788	69.6	1	SNP	p	D111H	0	.	.	331	333	GAT	606	608	GAT	71;72;73	G;A,C;T	71;70,1;73	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3608	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2788	69.6	1	SNP	p	S129P	0	.	.	385	387	TCC	660	662	TCC	78;79;78	T;C;C	76;79;76	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	2232	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2524	47.5	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1760	1762	GAT	77;78;78	G;A;T	76;78;78	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2246	patA	1380	1380	99.86	patA.l15.c30.ctg.1	2106	57.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1423	1425	GAT	56;57;58	G;A;T	56;57;56	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	V146F	0	.	.	436	438	GTT	754	756	GTT	88;89;89	G;T;T	88;89;88	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1855	1857	CAG	88;88;89	C;A;G	87;87;88	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1855	1857	CAG	88;88;89	C;A;G	87;87;88	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1894	1896	CAC	79;78;74	C;A;C	79;78;74	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1903	1905	CGT	65;64;62	C;G;T	64;63;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1903	1905	CGT	65;64;62	C;G;T	64;63;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1909	1911	TCC	65;65;64	T;C;C	64;65;64	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1915	1917	CTC	63;62;61	C;T;C	62;61;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	T563P	0	.	.	1687	1689	ACC	2005	2007	ACC	106;107;109	A;C;C	105;105;107	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	P564L	0	.	.	1690	1692	CCT	2008	2010	CCT	107;106;106	C;C;T	107;106;106	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6890	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4635	80.0	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2377	2379	CGT	95;95;94	C;G;T	94;95;93	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	.	n	.	0	A226G	SNP	226	226	A	389	389	G	660	G	658	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	1	SNP	n	A794T	0	.	.	794	794	A	957	957	A	586	A	578	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	1	SNP	n	A794G	0	.	.	794	794	A	957	957	A	586	A	578	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	1	SNP	n	G926C	0	.	.	926	926	G	1089	1089	G	577	G	576	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	1	SNP	n	G926A	0	.	.	926	926	G	1089	1089	G	577	G	576	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	1	SNP	n	G926T	0	.	.	926	926	G	1089	1089	G	577	G	576	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	1	SNP	n	A1519T	0	.	.	1519	1519	A	1682	1682	A	519	A	510	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	1	SNP	n	A1519C	0	.	.	1519	1519	A	1682	1682	A	519	A	510	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	1	SNP	n	A1519G	0	.	.	1519	1519	A	1682	1682	A	519	A	510	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	G474A	.	474	474	G	637	637	G	604	G,A	473,126	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	C194T	.	194	194	C	357	357	C	643	C,T	531,108	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	C422T	.	422	422	C	585	585	C	670	C,T	582,85	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	G1002A	.	1002	1002	G	1165	1165	G	599	G,A	443,155	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	G1006C	.	1006	1006	G	1169	1169	G	615	G,C	453,153	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	A79G	.	79	79	A	242	242	A	601	A,G	436,156	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	C719T	.	719	719	C	882	882	C	555	C,T	417,136	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	T273A,C	.	273	273	T	436	436	T	568	T,A,C	414,145,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	T1010C,G	.	1010	1010	T	1173	1173	T	617	T,C,G	450,156,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	C1038T	.	1038	1038	C	1201	1201	C	530	C,T	327,201	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	C1137A	.	1137	1137	C	1300	1300	C	598	C,A	520,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	C183T	.	183	183	C	346	346	C	627	C,T	512,113	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	T90C	.	90	90	T	253	253	T	581	T,C	413,162	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	A250T	.	250	250	A	413	413	A	586	A,T	439,142	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	19376	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.2	1885	534.1	0	HET	.	.	.	A253T,C	.	253	253	A	416	416	A	575	A,T,C	426,141,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	868	soxR	465	465	100.0	soxR.l6.c30.ctg.1	1052	44.2	1	SNP	p	R20H	0	.	.	58	60	CGC	319	321	CGC	82;83;86	C;G;C	81;83;86	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	868	soxR	465	465	100.0	soxR.l6.c30.ctg.1	1052	44.2	1	SNP	p	G121D	0	.	.	361	363	GGT	622	624	GGT	66;69;69	G;G;T	66;69;69	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	680	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	1005	36.2	1	SNP	p	A12S	0	.	.	34	36	GCA	406	408	GCA	86;89;88	G;C;A	86;87;87	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	17	5102	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l6.c30.ctg.1	1831	144.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	51	4612	APH_6__Id+	837	833	100.0	APH_6__Id+.l15.c30.ctg.1	1173	181.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	3728	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1425	139.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	2390	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	2154	59.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
